Spatial Distribution and Burden of Emerging Arboviruses in French Guiana.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
02 07 2021
Historique:
received: 08 06 2021
revised: 25 06 2021
accepted: 29 06 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 15 12 2021
Statut: epublish

Résumé

Despite the health, social and economic impact of arboviruses in French Guiana, very little is known about the extent to which infection burden is shared between individuals. We conducted a large multiplexed serological survey among 2697 individuals from June to October 2017. All serum samples were tested for IgG antibodies against DENV, CHIKV, ZIKV and MAYV using a recombinant antigen-based microsphere immunoassay with a subset further evaluated through anti-ZIKV microneutralization tests. The overall DENV seroprevalence was estimated at 73.1% (70.6-75.4) in the whole territory with estimations by serotype at 68.9% for DENV-1, 38.8% for DENV-2, 42.3% for DENV-3, and 56.1% for DENV-4. The overall seroprevalence of CHIKV, ZIKV and MAYV antibodies was 20.3% (17.7-23.1), 23.3% (20.9-25.9) and 3.3% (2.7-4.1), respectively. We provide a consistent overview of the burden of emerging arboviruses in French Guiana, with useful findings for risk mapping, future prevention and control programs. The majority of the population remains susceptible to CHIKV and ZIKV, which could potentially facilitate the risk of further re-emergences. Our results underscore the need to strengthen MAYV surveillance in order to rapidly detect any substantial changes in MAYV circulation patterns.

Identifiants

pubmed: 34372505
pii: v13071299
doi: 10.3390/v13071299
pmc: PMC8310293
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Bull Pan Am Health Organ. 1995 Jun;29(2):147-55
pubmed: 7640693
J Clin Virol. 2016 Apr;77:66-8
pubmed: 26921736
PLoS Negl Trop Dis. 2016 Apr 29;10(4):e0004681
pubmed: 27128312
Euro Surveill. 2017 Nov;22(44):
pubmed: 29113627
Am J Trop Med Hyg. 1998 Sep;59(3):452-6
pubmed: 9749643
PLoS One. 2017 Feb 14;12(2):e0172267
pubmed: 28196111
Biomed Res Int. 2015;2015:678084
pubmed: 26457301
Med Clin North Am. 2008 Nov;92(6):1377-90, x
pubmed: 19061757
Bull Soc Pathol Exot. 1996;89(2):98-100; discussion 101
pubmed: 8924782
Nat Commun. 2020 Jun 5;11(1):2842
pubmed: 32503971
PLoS Pathog. 2014 Oct 02;10(10):e1004386
pubmed: 25275316
Rev Panam Salud Publica. 2006 Dec;20(6):407-15
pubmed: 17341332
Bull Soc Pathol Exot. 1996;89(2):115-9
pubmed: 8924768
J Infect Dis. 2019 Nov 6;220(12):1915-1925
pubmed: 31418012
PLoS Negl Trop Dis. 2015 Nov 20;9(11):e0004226
pubmed: 26588076
PLoS Negl Trop Dis. 2014 Nov 06;8(11):e3235
pubmed: 25375627
Am J Trop Med Hyg. 2017 Aug;97(2):344-355
pubmed: 28722640
J Am Med Inform Assoc. 2014 Oct;21(e2):e232-40
pubmed: 24549761
Stud Health Technol Inform. 2011;169:629-33
pubmed: 21893824
mBio. 2016 Oct 11;7(5):
pubmed: 27729507
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
PLoS Negl Trop Dis. 2020 Mar 24;14(3):e0008193
pubmed: 32208419
Am J Trop Med Hyg. 2010 Jan;82(1):128-35
pubmed: 20065008
Antiviral Res. 2010 Aug;87(2):111-24
pubmed: 19616028
BMJ Glob Health. 2018 Jan 4;3(Suppl 1):e000530
pubmed: 29435366
Am J Trop Med Hyg. 1994 Nov;51(5):545-53
pubmed: 7985746
Trop Med Health. 2011 Dec;39(4 Suppl):3-11
pubmed: 22500131
Am J Trop Med Hyg. 2012 Oct;87(4):584-93
pubmed: 23042846
Expert Rev Vaccines. 2011 May;10(5):563-5
pubmed: 21604976
PLoS Negl Trop Dis. 2016 Nov 1;10(11):e0005081
pubmed: 27802275
Mem Inst Oswaldo Cruz. 2018 Mar 12;113(5):e170398
pubmed: 29538490
Lancet. 2016 Apr 9;387(10027):1531-1539
pubmed: 26948433
Nat Microbiol. 2019 May;4(5):854-863
pubmed: 30833735
One Health. 2017 Jul 01;4:1-13
pubmed: 28785601
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006533
pubmed: 30011271
Elife. 2019 Apr 08;8:
pubmed: 30958263
Nature. 2018 May;557(7707):719-723
pubmed: 29795354

Auteurs

Sarah Bailly (S)

Epidemiology Unit, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Dominique Rousset (D)

Arbovirus National Reference Center, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Camille Fritzell (C)

Epidemiology Unit, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Nathanaël Hozé (N)

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, 75015 Paris, France.

Sarrah Ben Achour (S)

Arbovirus National Reference Center, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Léna Berthelot (L)

Arbovirus National Reference Center, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Antoine Enfissi (A)

Arbovirus National Reference Center, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Jessica Vanhomwegen (J)

Environment and Infectious Risks Unit, Institut Pasteur, 75015 Paris, France.

Henrik Salje (H)

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, 75015 Paris, France.
Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK.

Sandrine Fernandes-Pellerin (S)

Clinical Coordination of Translational Research Center, Institut Pasteur, 75015 Paris, France.

Mona Saout (M)

Epidemiology Unit, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Anne Lavergne (A)

Arbovirus National Reference Center, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.

Jean-Claude Manuguerra (JC)

Environment and Infectious Risks Unit, Institut Pasteur, 75015 Paris, France.

Jean-François Carod (JF)

Medical Laboratory, Centre Hospitalier de l'Ouest Guyanais, 97320 Saint-Laurent du Maroni, French Guiana.

Félix Djossou (F)

Infectious and Tropical Diseases Unit, Centre Hospitalier Andrée Rosemon, 97300 Cayenne, French Guiana.

Simon Cauchemez (S)

Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, 75015 Paris, France.

Claude Flamand (C)

Epidemiology Unit, Institut Pasteur in French Guiana, 97300 Cayenne, French Guiana.
Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH